Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 476

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 476
---
 Options, Warrants 
     and Rights(2) |     |  Weighted Average 
 Exercise Price of 
       Outstanding 
          Options, 
      Warrants and 
         Rights(2) |     |    Number of Securities 
     Remaining Available 
                     for 
   Future Issuance under 
     the Plan (excluding 
 securities reflected in 
          column (a)(2)) |
|                                                            |     |                -a |     |                -b |     |                      -c |
| Equity compensation plans approved by security holders(1)  |     |         1,004,437 |     |             $5.58 |     |                 940,007 |
| Equity compensation plans not approved by security holders |     |                   |     |                   |     |                         |
| Total                                                      |     |                   |     |                   |     |                 940,007 |

| (1) | Represents the shares of Channel common stock authorized for issuance under the Amended and Restated 2023 Plan. In February 2024, the Channel board of directors approved an amendment to the Prior Plan, subject to stockholder approval which was subsequently obtained. An aggregate of 3,000,000 shares were originally authorized for issuance under the Prior Plan, and after the amendment and Channel’s Reverse Stock Split in connection with the IPO, an aggregate of 444,444 shares have been authorized under the Prior Plan. On June 12, 2024, the Channel board of directors authorized an amendment to the Prior Plan to increase the number of shares of Channel common stock authorized for issuance thereunder by 1,500,000 from 444,444 shares to 1,944,444 shares. On October 22, 2024, the increase in the number of shares in the Prior Plan was approved by the affirmative vote of a majority of the outstanding shares of Channel common stock present in person, by remote communication, if applicable, or represented by proxy at the Annual Meeting. As of May 2, 2025, options to purchase an aggregate of 1,004,437 shares of Channel common stock with a weighted-average exercise price of $5.58 per share, were outstanding under the Amended and Restated 2023 Plan, with 940,007 shares of Channel common stock remaining available for future issuance. Unissued shares subject to awards that expire, are forfeited, or are cancelled will again become available for issuance under the Amended and Restated 2023 Plan. |

|